Meeting Highlights from AACE 28th Annual Scientific & Clinical Congress

April 24-28, 2019
Los Angeles Convention Center Los Angeles, CA

The American Association of Clinical Endocrinologists hosted more than 80 sessions and about 500 posters and abstract prasentations during AACE 2019 who convened to exchange insights aimed at enhancing patient care through shared information, networking, and presenting advances in care.

While EndocrineWeb shares highlights of the plentary session presented byi Felice Cosman, MD, on the benefits of prescribing anaboic agents to better protect women aganst bone loss, the topic recieved reinformcemtn given that 

Recognizing exemplery poster presentation efforts, Ruban Dhaliwal, MD, MPH, an assistant professor of medicine at SUNY Update Medical University received first place for his work on the Effect of Abaloparatide followed by Alendroneate on Bone Density and Fractice Incidence in Post-Menopausal Women with Osteoporosis and Type 2 Diabetes.

In a new feature when reporting from professional conferences, EndocrineWeb brings you on-the-ground interviews with attendees who share their "ah ha" moments to give you a sense of the practical takeways that practitioners in attendence found insightful. At AACE 2019, the aha moments included the limits of omega 3 fatty acids, 


Start planning now for AACE 2020, as the annual meeting returns to the East Coast, taking place May 6 to 10, 2020 in Washtington, DC.

Last updated on
First Article From This Meeting:
Anabolic Agents Superior as First-Line Therapy in Patients at Highest Risk
close X